Final Bench Testing Guidance Clarifies FDA Expectations

Newly finalized guidance from the US Food and Drug Administration lays out how device developers should present information from non-clinical bench performance testing in premarket submissions.

The 25 April document includes formatting and content recommendations for test report summaries, test protocols, and complete test reports submitted as part of the premarket process. It’s meant to...